Chinese biotech firms showcase rapid drug development at Shanghai Science City conference

Jefferies hosted its first investor conference in Shanghai’s high‑tech Science City district, gathering leaders of several fast‑growing Chinese biotech companies on a stage at the Hilton ballroom.

The executives highlighted how drug development in China is becoming faster, cheaper, and more efficient than in the United States and Europe, suggesting the country is emerging as a new hub for biotech innovation.

Zhui Chen, co‑founder of Shanghai‑based Abbisko, recounted a recent trial of a Merck KGaA‑licensed drug that wrapped up in just 11 months, prompting Merck officials to ask whether Abbisko could train their staff on the accelerated process.

The event underscored the rapid expansion of China’s biotech sector and its growing appeal to global investors and partners seeking to tap into the country’s accelerated development timelines.